Furthermore, assessment across cancer types revealed recurrent mutation sites in SHPRH, including mutations at G458 (non-sense or frameshift deletions in 8 cases, including LUAD), G587 (missense or frameshift deletions/insertions in 8 cases) and R1365 (R1365C in 5 cases). This evidence concerns the gene SHPRH and cancer.